Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of Ear Nerve Stimulation to Treat Eye Inflammation

NCT: NCT07831876 · RECRUITING

NCT IDNCT07831876
StatusRECRUITING
Start Date2026-09-09
Completion2028-09-09
SponsorMemorial Sloan Kettering Cancer Center (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study to find out whether a device that delivers mild electrical stimulation to the ear (transcutaneous auricular vagus nerve stimulation, or taVNS) can reduce inflammation in the eye in people with ocular inflammatory conditions. The device is called the Cymbathera One System.

Frequently Asked Questions

What is A Study of Ear Nerve Stimulation to Treat Eye Inflammation?

A Study of Ear Nerve Stimulation to Treat Eye Inflammation is a clinical trial registered under NCT07831876. Current status: RECRUITING.

What is the status of NCT07831876?

The current status of NCT07831876 (A Study of Ear Nerve Stimulation to Treat Eye Inflammation) is: RECRUITING.

When did A Study of Ear Nerve Stimulation to Treat Eye Inflammation start?

A Study of Ear Nerve Stimulation to Treat Eye Inflammation started on 2026-09-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.